Free Trial

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$4.99 +0.03 (+0.50%)
As of 10:56 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CLOV vs. OSCR, HQY, ALHC, UNH, and ELV

Should you buy Clover Health Investments stock or one of its competitors? Clover Health Investments's main competitors and comparable companies include Oscar Health (OSCR), HealthEquity (HQY), Alignment Healthcare (ALHC), UnitedHealth Group (UNH), and Elevance Health (ELV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Clover Health Investments compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Oscar Health currently has a consensus price target of $34.60, suggesting a potential upside of 11.09%. Clover Health Investments has a consensus price target of $5.10, suggesting a potential upside of 2.82%. Given Oscar Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Oscar Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 22.6% of Oscar Health shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Oscar Health has a beta of 2.56, meaning that its share price is 156% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.52, meaning that its share price is 152% more volatile than the broader market.

Oscar Health has a net margin of 4.90% compared to Clover Health Investments' net margin of 0.45%. Oscar Health's return on equity of 49.39% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health4.90% 49.39% 9.29%
Clover Health Investments 0.45%4.66%2.43%

In the previous week, Clover Health Investments had 1 more articles in the media than Oscar Health. MarketBeat recorded 7 mentions for Clover Health Investments and 6 mentions for Oscar Health. Clover Health Investments' average media sentiment score of 0.82 beat Oscar Health's score of 0.39 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Clover Health Investments has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.83-$443.15M$2.4212.87
Clover Health Investments$2.74B0.97-$85.55M$0.01496.00

Summary

Oscar Health beats Clover Health Investments on 11 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to HealthEquity?

Clover Health Investments (NASDAQ:CLOV) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of 0.45%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments0.45% 4.66% 2.43%
HealthEquity 17.36%15.33%9.51%

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Clover Health Investments has a beta of 2.52, meaning that its stock price is 152% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

HealthEquity has lower revenue, but higher earnings than Clover Health Investments. HealthEquity is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$2.74B0.97-$85.55M$0.01496.00
HealthEquity$1.36B6.28$215.20M$2.7737.35

Clover Health Investments presently has a consensus price target of $5.10, indicating a potential upside of 2.82%. HealthEquity has a consensus price target of $113.53, indicating a potential upside of 9.74%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92

In the previous week, Clover Health Investments had 5 more articles in the media than HealthEquity. MarketBeat recorded 7 mentions for Clover Health Investments and 2 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.63 beat Clover Health Investments' score of 0.82 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthEquity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

HealthEquity beats Clover Health Investments on 12 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Alignment Healthcare?

Clover Health Investments (NASDAQ:CLOV) and Alignment Healthcare (NASDAQ:ALHC) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

In the previous week, Alignment Healthcare had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 9 mentions for Alignment Healthcare and 7 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.82 beat Alignment Healthcare's score of 0.71 indicating that Clover Health Investments is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alignment Healthcare
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alignment Healthcare has a net margin of 0.59% compared to Clover Health Investments' net margin of 0.45%. Alignment Healthcare's return on equity of 12.46% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments0.45% 4.66% 2.43%
Alignment Healthcare 0.59%12.46%2.36%

Clover Health Investments has a beta of 2.52, indicating that its stock price is 152% more volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Alignment Healthcare has higher revenue and earnings than Clover Health Investments. Alignment Healthcare is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$2.74B0.97-$85.55M$0.01496.00
Alignment Healthcare$3.95B0.39-$720K$0.1356.62

Clover Health Investments presently has a consensus target price of $5.10, indicating a potential upside of 2.82%. Alignment Healthcare has a consensus target price of $14.00, indicating a potential upside of 90.22%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
Alignment Healthcare
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Summary

Alignment Healthcare beats Clover Health Investments on 10 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

UnitedHealth Group currently has a consensus target price of $463.93, indicating a potential upside of 13.82%. Clover Health Investments has a consensus target price of $5.10, indicating a potential upside of 2.82%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe UnitedHealth Group is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.71
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

In the previous week, UnitedHealth Group had 29 more articles in the media than Clover Health Investments. MarketBeat recorded 36 mentions for UnitedHealth Group and 7 mentions for Clover Health Investments. UnitedHealth Group's average media sentiment score of 1.14 beat Clover Health Investments' score of 0.82 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
26 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group has higher revenue and earnings than Clover Health Investments. UnitedHealth Group is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.82$12.06B$17.5123.28
Clover Health Investments$2.74B0.97-$85.55M$0.01496.00

UnitedHealth Group has a net margin of 3.53% compared to Clover Health Investments' net margin of 0.45%. UnitedHealth Group's return on equity of 17.95% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group3.53% 17.95% 5.95%
Clover Health Investments 0.45%4.66%2.43%

UnitedHealth Group has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.52, suggesting that its stock price is 152% more volatile than the broader market.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 0.2% of UnitedHealth Group shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

UnitedHealth Group beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Elevance Health?

Elevance Health (NYSE:ELV) and Clover Health Investments (NASDAQ:CLOV) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

Elevance Health has higher revenue and earnings than Clover Health Investments. Elevance Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.47$5.66B$23.4518.32
Clover Health Investments$2.74B0.97-$85.55M$0.01496.00

Elevance Health has a net margin of 2.55% compared to Clover Health Investments' net margin of 0.45%. Elevance Health's return on equity of 14.97% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.55% 14.97% 5.31%
Clover Health Investments 0.45%4.66%2.43%

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Elevance Health presently has a consensus target price of $456.48, suggesting a potential upside of 6.28%. Clover Health Investments has a consensus target price of $5.10, suggesting a potential upside of 2.82%. Given Elevance Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Elevance Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
7 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.68
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

Elevance Health has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.52, meaning that its share price is 152% more volatile than the broader market.

In the previous week, Elevance Health had 8 more articles in the media than Clover Health Investments. MarketBeat recorded 15 mentions for Elevance Health and 7 mentions for Clover Health Investments. Elevance Health's average media sentiment score of 1.21 beat Clover Health Investments' score of 0.82 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
11 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Elevance Health beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.67B$10.96B$7.91B$11.89B
Dividend YieldN/A2.54%2.47%4.41%
P/E Ratio500.0036.3634.5230.32
Price / Sales0.972.058.155.41
Price / CashN/A23.2821.0222.32
Price / Book8.453.994.753.90
Net Income-$85.55M$335.01M$3.52B$391.39M
7 Day Performance3.21%-3.03%-3.82%-3.22%
1 Month Performance11.27%-0.27%-2.07%-4.61%
1 Year Performance101.82%21.15%0.68%-6.60%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
2.9016 of 5 stars
$4.99
+0.5%
$5.10
+2.3%
+100.8%$2.67B$2.74B500.00724
OSCR
Oscar Health
4.5288 of 5 stars
$31.81
-0.9%
$34.60
+8.8%
+124.7%$9.91B$11.70B13.142,305
HQY
HealthEquity
3.799 of 5 stars
$103.05
+0.0%
$113.53
+10.2%
+1.7%$8.52B$1.31B37.202,814
ALHC
Alignment Healthcare
3.683 of 5 stars
$7.50
-2.5%
$14.00
+86.7%
-55.4%$1.61B$3.95B57.701,849
UNH
UnitedHealth Group
4.8633 of 5 stars
$405.45
+0.6%
$463.93
+14.4%
+26.8%$361.04B$447.57B23.16390,000

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners